Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries SciSparc Ltd. - Ordinary Shares (NQ: SPRC ) 0.7085 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about SciSparc Ltd. - Ordinary Shares < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million July 17, 2024 From SciSparc Ltd Via GlobeNewswire Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 16, 2024 Via Benzinga SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification July 16, 2024 From SciSparc Ltd Via GlobeNewswire Mizuho Just Issued a Warning on Palantir (PLTR) Stock July 16, 2024 Palantir Technologies stock is down on Tuesday after shares of PLTR were hit with a downgrade from Mizuho analysts this morning. Via InvestorPlace Why Is SciSparc (SPRC) Stock Up 25% Today? July 16, 2024 SciSparc stock is up on Tuesday as SPRC investors learn of the company filing a new patent covering its weight loss treatment. Via InvestorPlace Topics Intellectual Property Exposures Intellectual Property Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 16, 2024 It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning! Via InvestorPlace SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss July 16, 2024 From SciSparc Ltd Via GlobeNewswire Why WD-40 Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket July 11, 2024 Via Benzinga SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company July 08, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Secures Strategic Advantage with Grant of European Patent May 31, 2024 From SciSparc Ltd Via GlobeNewswire Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 16, 2024 Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates. Via Benzinga Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket April 16, 2024 Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corporation (NASDAQ: WFTC) and Macatawa Bank announced that they have entered into... Via Benzinga Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 11, 2024 Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Via Benzinga SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification April 11, 2024 SciSparc to acquire AutoMax Motors, forming a new entity with SciSparc owning over 50%. SciSparc's core operations to continue. Via Benzinga SciSparc to Acquire AutoMax April 11, 2024 From SciSparc Ltd Via GlobeNewswire Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket April 11, 2024 Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant... Via Benzinga SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression March 27, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research March 21, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Granted Another Patent, Strengthening its Core Technology in Canada March 18, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial March 14, 2024 From SciSparc Ltd Via GlobeNewswire Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors March 12, 2024 Via Benzinga SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure March 12, 2024 From SciSparc Ltd Via GlobeNewswire Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments March 08, 2024 The first patient has been enrolled in SciSparc Ltd.'s clinical trial evaluating the effectiveness and safety of their CBD-based drug for treating children with autism spectrum disorder, marking a... Via Benzinga Topics Intellectual Property Exposures Intellectual Property SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder March 08, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe March 07, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology March 06, 2024 From SciSparc Ltd Via GlobeNewswire Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More March 04, 2024 Via Benzinga SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing February 29, 2024 From SciSparc Ltd Via GlobeNewswire SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds February 27, 2024 From SciSparc Ltd Via GlobeNewswire Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds February 27, 2024 From Clearmind Medicine Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.